About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Solara Active Pharma Sciences Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
541540
ISIN Demat
INE624Z01016
Book Value
229.75
NSE Code
SOLARA
Dividend Yield %
0.00
Market Cap
22784.34
P/E
0.00
EPS
-0.22
Face Value
10
BSE
NSE
06-Jun-2025 14:56
BSE
NSE
NSE F & O
06-Jun-2025 14:49
BSE
NSE
NSE F & O
Last Price
474.15
Net Change
2.5
% Change
0.53%
Prev.Close
471.65
Open
475.40
High
476.95
Low
472.15
Volume
2078
Last Price
474.95
Net Change
2.1
% Change
0.44%
Prev.Close
472.85
Open
476.00
High
476.45
Low
472.05
Volume
36727
Value
985283.7
Best Buy
474.10
Best Sell
475.10
Best Quantity
4
Sell Quantity
50
Today's Range
476.95
52-Week High
885.95
52-Week Low
392.00
Value
17443488.65
Best Buy
474.60
Best Sell
474.95
Best Quantity
31
Sell Quantity
36
Today's Range
476.45
52-Week High
882.80
52-Week Low
390.95
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
4
Price
474.10
Quantity
50
Price
475.10
Best Bid
Best Offer
Quantity
31
Price
474.60
Quantity
36
Price
474.95
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
18-Sep-24
20-Sep-24
Rights
1 : 3
15-May-24
Dividend
30 %
21-Aug-21
Company News
10-05-2025
USFDA concludes inspectio...
07-05-2025
Solara Active Pharma Scie...
06-05-2025
Solara Active Pharma info...
05-05-2025
Solara Active Pharma Scie...
30-04-2025
Solara Active Pharma Scie...
17-04-2025
Solara Active Pharma Sci...
07-02-2025
Solara Active Pharma Scie...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
